Bacillus Calmette–Guérinvaccine
Bill of Testing
Clinical Development Plan
Clinical
Chemistry, Manufacturing, and Controls
Cost Of Goods
Critical Process Parameters
Critical Quality Attributes
Clinical Trial Application
Clinical Trial Material
Drug product
Drug substance
Ethics Committee
European Medicines Agency
First In Human
Global Alliance for Vaccines and Immunisation
Genetically Modified Organism
Good Manufacturing Practice
Health Economics and Outcome Research
Investigational Brochure
Intellectual Property
Key Opinion Leader
Material transfer agreement
Mycobacterium tuberculosis
Non Human Primate
National Immunization Programs
National Regulatory Authority
Pre-clinical
Product Development Plan
Prinicipal Investigator
Project management
Prevention of Infection (endpoint)
Proof of Concept
Quality Control test
Regulatory Authority
Risk Management Programme
Stage Gate Criteria
Tuberculosis
Target Product Profile
World Health Organization
WHO prequalification process
